GLUE
Monte Rosa Therapeutics Inc
11.80$
+0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -154.3% | |
| – | +645.8% | +297.0% | +75.7% | +66.1% | +30.5% | +2.9% | |
| – | – | +1,368.9% | +124.3% | +42.9% | +8.7% | +4.1% | |
| – | – | -35.1% | +121.5% | – | – | – | |
| – | +140.3% | +47.7% | -133.9% | – | +26.1% | -110.1% | |
| – | +144.7% | +187.2% | +32.7% | +47.5% | -79.1% | +17.9% | |
| – | +144.7% | +184.8% | +2,171.0% | – | -150.1% | +129.1% | |
| – | – | – | -94.5% | -100.6% | +452.6% | -44.3% | |
| – | – | – | – | – | – | – | |
| – | +300.4% | +528.6% | -94.6% | +34.3% | +259.7% | -69.3% | |
| – | +336.1% | +850.7% | -194.4% | – | +33.0% | -197.8% | |
| – | – | – | – | – | – | -172.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.